Terms: = Leukemia AND TG, Thyroglobulin AND Treatment
184 results:
1. The feasibility of implementing Toronto childhood cancer stage guidelines and estimating the impact on outcome for childhood cancers in seven pediatric oncology units in sub-Saharan Africa. A study from the Franco-African Pediatric Oncology Group.
Mallon B; Kaboré R; Couitchere L; Akonde FB; Narison MLR; Budiongo A; Dackono TA; Pondy A; Diedhiou F; Patte C; Steliarova-Foucher E; Clavel J
Pediatr Blood Cancer; 2023 Dec; 70(12):e30664. PubMed ID: 37732944
[TBL] [Abstract] [Full Text] [Related]
2.
Al-Zayan NR; Ashour MJ; Abuwarda HN; Sharif FA
Pediatr Hematol Oncol; 2024; 41(2):103-113. PubMed ID: 37578068
[TBL] [Abstract] [Full Text] [Related]
3. Tyrosine Kinase Inhibitor Therapies in Chronic Myeloid leukemia: Effects on Clinical Characteristics and Triglyceride-to-High Density Lipoprotein Cholesterol Ratio.
Erkek ET; Isik AC; Ipek Y; Kul AN
Niger J Clin Pract; 2023 Jun; 26(6):802-809. PubMed ID: 37470656
[TBL] [Abstract] [Full Text] [Related]
4. Development of Curcumin and Piperine-Loaded Bio-Active Self-Nanoemulsifying Drugs and Investigation of Their Bioactivity in Zebrafish Embryos and Human Hematological Cancer Cell Lines.
Kazi M; Khan MF; Nasr FA; Ahmed MZ; Alqahtani AS; Ali MM; Aldughaim MS
Int J Nanomedicine; 2023; 18():1793-1808. PubMed ID: 37051315
[TBL] [Abstract] [Full Text] [Related]
5. TG-interacting factor 1 improves risk stratification in patients with NPM1-mutated acute myeloid leukemia.
Tang H; Zhang N; Li H; Chen Y; Liu X; Xiao H; Deng J; Zhou K
Adv Clin Exp Med; 2023 Jul; 32(7):741-751. PubMed ID: 36753372
[TBL] [Abstract] [Full Text] [Related]
6. MicroRNA-211-5p Overexpression Effect on Endoplasmic Reticulum Stress and Apoptotic Genes in Fibroblast-like Synoviocytes of Rheumatoid Arthritis.
Farghadan M; Zavaran-Hosseini A; Farhadi E; Sharafat Vaziri A; Tahmasebi MN; Jamshidi A; Mahmoudi M
Iran J Allergy Asthma Immunol; 2022 Aug; 21(4):418-428. PubMed ID: 36243930
[TBL] [Abstract] [Full Text] [Related]
7. JAK/BCL2 inhibition acts synergistically with LSD1 inhibitors to selectively target ETP-ALL.
Benyoucef A; Haigh K; Cuddihy A; Haigh JJ
Leukemia; 2022 Dec; 36(12):2802-2816. PubMed ID: 36229595
[TBL] [Abstract] [Full Text] [Related]
8. A Retrospective Cohort Study of the Efficacy, Safety, and Clinical Value of 6-TG versus 6-MP Maintenance Therapy in Children with Acute Lymphoblastic leukemia.
Tu M; Zhang A; Hu L; Wang F
Biomed Res Int; 2022; 2022():7580642. PubMed ID: 36046443
[TBL] [Abstract] [Full Text] [Related]
9. [Apoptosis of Megakaryocytic leukemia Cell Line Meg-01 Induced by TSP-1 Via CD36/Caspase-3].
Kong HM; Su WQ; Luo Y; Ge H; Li L; Yang M; Jiang QL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):998-1004. PubMed ID: 35981353
[TBL] [Abstract] [Full Text] [Related]
10. Induction of chronic lymphocytic leukemia-like disease in STYK1/NOK transgenic mice.
Yang Y; Liu L; Tucker HO
Biochem Biophys Res Commun; 2022 Oct; 626():51-57. PubMed ID: 35970044
[TBL] [Abstract] [Full Text] [Related]
11. IL-2 and Zoledronic Acid Therapy Restores the
Mylabathula PL; Diak DM; Baker FL; Niemiro GM; Markofski MM; Crucian BE; Katsanis E; Simpson RJ
Front Biosci (Landmark Ed); 2022 Jul; 27(7):215. PubMed ID: 35866402
[TBL] [Abstract] [Full Text] [Related]
12. Maintenance therapy for acute lymphoblastic leukemia: basic science and clinical translations.
Toksvang LN; Lee SHR; Yang JJ; Schmiegelow K
Leukemia; 2022 Jul; 36(7):1749-1758. PubMed ID: 35654820
[TBL] [Abstract] [Full Text] [Related]
13. Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0-45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol.
Toksvang LN; Als-Nielsen B; Bacon C; Bertasiute R; Duarte X; Escherich G; Helgadottir EA; Johannsdottir IR; Jónsson ÓG; Kozlowski P; Langenskjöld C; Lepik K; Niinimäki R; Overgaard UM; Punab M; Räty R; Segers H; van der Sluis I; Smith OP; Strullu M; Vaitkevičienė G; Wik HS; Heyman M; Schmiegelow K
BMC Cancer; 2022 May; 22(1):483. PubMed ID: 35501736
[TBL] [Abstract] [Full Text] [Related]
14. Novel Compound, ND-17, Regulates the JAK/STAT, PI3K/AKT, and MAPK Pathways and Restrains Human T-lymphoid leukemia Development.
Ma W; Liu Y; Lei P; Zhu M; Pan X
Curr Cancer Drug Targets; 2022; 22(5):404-413. PubMed ID: 35249489
[TBL] [Abstract] [Full Text] [Related]
15. Analysis of serum lipid parameters predicting lipid metabolic disorders in TSC-AML patients with treatment of mTOR inhibitors.
Wang W; Wang Z; Zhao Y; Wang X; Li H; Zhang Y
J Clin Pharm Ther; 2022 Jul; 47(7):979-985. PubMed ID: 35229896
[TBL] [Abstract] [Full Text] [Related]
16. Subclinical Hypothyroidism as the Most Common Thyroid Dysfunction Status in Children With Down's Syndrome.
Szeliga K; Antosz A; Skrzynska K; Kalina-Faska B; Januszek-Trzciakowska A; Gawlik A
Front Endocrinol (Lausanne); 2021; 12():782865. PubMed ID: 35058880
[TBL] [Abstract] [Full Text] [Related]
17. 6-Thioguanine Inhibits Herpes Simplex Virus 1 Infection of Eyes.
Chen D; Liu Y; Zhang F; You Q; Ma W; Wu J; Wu Z
Microbiol Spectr; 2021 Dec; 9(3):e0064621. PubMed ID: 34730435
[TBL] [Abstract] [Full Text] [Related]
18. Cost-effectiveness of a 12-month fixed-duration venetoclax treatment in combination with obinutuzumab in first-line, unfit chronic lymphocytic leukemia in the United States.
Chatterjee A; Shapouri S; Manzoor BS; Ravelo A; Sail K; Qendri V; van de Wetering G; Davids MS
J Manag Care Spec Pharm; 2021 Nov; 27(11):1532-1544. PubMed ID: 34714110
[No Abstract] [Full Text] [Related]
19. Antitumor Activity of the Novel BTK Inhibitor TG-1701 Is Associated with Disruption of Ikaros Signaling in Patients with B-cell Non-Hodgkin Lymphoma.
Ribeiro ML; Reyes-Garau D; Vinyoles M; Profitós Pelejà N; Santos JC; Armengol M; Fernández-Serrano M; Sedó Mor A; Bech-Serra JJ; Blecua P; Musulen E; De La Torre C; Miskin H; Esteller M; Bosch F; Menéndez P; Normant E; Roué G
Clin Cancer Res; 2021 Dec; 27(23):6591-6601. PubMed ID: 34551904
[TBL] [Abstract] [Full Text] [Related]
20. Understanding thiopurine methyltransferase polymorphisms for the targeted treatment of hematologic malignancies.
Franca R; Braidotti S; Stocco G; Decorti G
Expert Opin Drug Metab Toxicol; 2021 Oct; 17(10):1187-1198. PubMed ID: 34452592
[TBL] [Abstract] [Full Text] [Related]
[Next]
